Private Market View

Capstan Therapeutics

Biotechnology

Last price · $/share
Implied valuation
Total raised
$340.0M
Last round
Early Stage VC (Series B)
Mar 2024
Investors — not yet on record

No investors in Capstan Therapeutics are on record yet. Backers surface from round announcements, filings, and coverage sessions.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 3 rounds
  • ·Watchlist + deal alerts for Capstan Therapeutics
Create free account
No card required